1

2

Mirrorgroup Animal Health

Dutch experiences

3

Trigger, initiative and chair

• Initiative: CVO• European trigger: request Executive Board of

ETPGAH to deliver input for Action Plan under construction

• National triggers: - need to strengthen Vet. Research infrastructure- improvement co-operation pharma industry, public research and administration (incl. Registration Authority)- innovation in vaccine development (AI)

• Lead: pharma industry (Intervet)

4

Targets

For Europe• Recommendations for Action Plan ETPGAH

- gaps and priorities from (shared) Dutch point of view- defining issues of major importance for NLResult: position paper

National• Improvement of understanding and co-

operation between and among industry, research, administration

5

Stakeholders

• Pharma Industry (Intervet, Pfizer, Fort Dodge, FIDIN)

• Research Institutes (Fac. Vet. Med., CIDC, ASG, Animal Health Service)

• Administration (CVO, Reg. Authority, 2 Departments of LNV)

• Royal Vet. Society

• Food and Product Safety Authority

6

Setting

• Temporary Group (max. 3 meetings)

• Informal end-afternoon meetings including buffet

• Time and opportunity for non-plenary interactions

7

Topics addressed in 1st meeting

1. Terms of reference Mirror Group and modus operandi ETPGAHConclusion: recommendations ETPGAH are in general very relevant for the Netherlands.

2. Clarification of positions and interactions of ETPGAH, SCAR-CWGAH, FP-7 agenda and ERA-net Animal diseases

3. Registration procedures and thresholds for pharma industry

8

Main conclusions 1st meeting

National level• Research chain (fundamental to farm) interacts

poorly with industry• Co-operation with industry is hampered by

competition between companies• Co-operation with human health research should

be improved

European level• Strong support for European Centre for

Epidemiology and Infectious Diseases• Co-operation with human health policy and

research should be improved

9

2nd (final) meeting

Agenda: discussion of priorities in draft Action Plan

Major comments and recommendations:• More and sharper choices needed in research

programming• Need for stronger interaction and co-operation between

domains of animal and human health• Need for European Centre for Epidemiology and

Infectious diseases is urgent; concern about continuity of budget if physical instead of virtual; task areas defined

• Special attention required for activities contributing to a consistent European approach of regulatory issues

10

Plan to continue (from 2008 on)

Terms of reference:• Input in (inter)national research agendas from a

shared opinion or mutual understanding of Dutch stakeholders;

• Improvement of understanding and co-operation among stakeholders on the national level

• Improvement of co-operation between human and animal health institutions

Modus operandi: informal platform with participation of human health institutions working in the field of zoonoses (both food-borne and non food-borne)

11

Direction of national research funding

Under construction because of recent National Policy Agenda Animal Health.

Longlist of topics:• Vaccine development for AI, AHS and RVF• BT-vaccination• Optimisation of vaccination strategies• Emerging zoonoses (also in companion animals)• Biology of vectors• Prevention and monitoring in non commercial animals• Differentiation of animal health policy• Elaboration of the OIE compartment concept• Improvement of early warning systems and tools• The concept of general disease resistance

12

Thank you for your attention

Time for questions